[Combined parenteral therapy with thiamazole and iodide in patients with severe hyperthyroidism. (Study on half-life of free and total plasma thyroxine)].
D000293:Adolescent; D000328:Adult; D013956:Antithyroid Agents / Q000008:administration & dosage*; D001322:Autoanalysis; D004357:Drug Synergism; D005260:Female; D006207:Half-Life; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D007093:Imidazoles / Q000008:administration & dosage*; D007275:Injections, Intravenous; D007454:Iodides / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism / Q000494:pharmacology; D008297:Male; D008713:Methimazole / Q000008:administration & dosage / Q000494:pharmacology; D008875:Middle Aged; D013961:Thyroid Gland / Q000187:drug effects; D013974:Thyroxine / Q000097:blood / Q000378:metabolism
D013956:Antithyroid Agents; D007093:Imidazoles; D007454:Iodides; D008713:Methimazole; D013974:Thyroxine
Kombinierte parenterale Therapie mit Thiamazol und Jodid bei schwerer Hyperthyreose. (Messung der Halbwertzeit von freiem und Gesamt-Thyroxin im Serum.